The bio-energetic theory of carcinogenesis

Medical Hypotheses

Volumn 79, Issue 4, 2012, Pages 433-439

  Gonzalez, Michael J ^a   Miranda Massari, Jorge R ^a   Duconge, Jorge ^a   Riordan, Neil H ^b   Ichim, Thomas ^b   Quintero Del Rio, Ana I ^c   Ortiz, Norma ^c  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b Riordan Clinic   (United States)

^c Puerto Rico Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; LACTIC ACID; OXYGEN;

ACIDITY; AEROBIC METABOLISM; ALKALINITY; ANAEROBIC FERMENTATION; ARTICLE; BIOCHEMISTRY; BIOENERGY; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ENERGY; CELL PROLIFERATION; CELL RESPIRATION; CELL TRANSFORMATION; CITRIC ACID CYCLE; ELECTRON TRANSPORT; ENERGY METABOLISM; ENERGY TRANSFER; ENZYME INACTIVATION; FERMENTATION; GENE EXPRESSION; GLUCOSE INTAKE; HUMAN; MALIGNANT TRANSFORMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN;

ANIMALS; ASCORBIC ACID; CELL DIFFERENTIATION; CELL MEMBRANE; ENERGY METABOLISM; FERMENTATION; GLYCOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN;

EID: 84865988105     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.06.015     Document Type: Article

References (48)

1. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
2. Bustamante E., Morris H.P., Pedersen P.L. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 1981, 256(16):8699-8704.
3. Moreno-Sánchez R., Rodríguez-Enríquez S., Marín-Hernández A., Saavedra E. Energy metabolism in tumor cells. FEBS J 2007, 274(6):1393-1418.
4. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
5. Szent-Györgyi A. Bioelectronics and cancer. J Bioenerg Biomembr 1973, 4(6):533-562.
6. Kremer H. Concept of cell symbiosis therapy 2008, Townsend Letter.
7. Mason M.D. Differentiation and cancer. Eur J Cancer 1992, 28(1):255-258.
8. Majerus M.A. The relationship between the cancer cell and the oocyte. Med Hypotheses 2002, 58(6):544-551.
9. Monk M., Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene 2001, 20:8085-8091.
10. Komarova S.V., Ataullakhanov F.I., Globus R.K. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol 2000, 279(4):C1220-C1229.
11. Cone C.D. The role of surface electrical transmembrane potential in normal and malignant mitogenesis. Ann NY Acad Sci 1975, 238:420-435.
12. Michelakis E.D. Mitochondrial medicine: a new era in medicine opens new windows and brings new challenges. Circulation 2008, 117:2431-2434.
13. Stipanuk M.A. Biochemical and physiological aspects of human nutrition 2000, W.B. Saunders Company, Philadelphia, PA.
14. De Robertis E.D.P. Cell and molecular biology 2008, Lippincott Williams and Williams. 8th ed.
15. Apell H.J. Electrogenic properties of the Na/K pump. J Membr Biol 1989, 110(2):103-114.
16. Sturmer W., Bühler R., Apell H.J., Läuger P. Charge translocation by the Na, K-pump II: ion binding and release at the extracellular face. J Membr Biol 1991, 121(2):163-176.
17. Bühler R., Stürmer W., Apell H.J., Läuger P. Charge translocation by the Na, K-pump I: kinetics of local field changes studied by time-resolved fluorescence measurements. J Membr Biol 1991, 121(2):141-161.
18. Cone C.D. The role of surface electrical transmembrane potential in normal and malignant mitogenesis. Ann NY Acad Sci 1974, 238:420-435.
19. Pappas PT and Wallach C. Effects of pulsed magnetic field oscillations in cancer therapy. Invited paper to Int'l Symposium on New Energy, Denver, April 16-18, 1993, sponsored by Int'l Association for New Science, Fort Collins, CO 80524.
20. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007, 11:37-51.
21. Gogvadze V., Orrennius S., Zhivotovsky B. Mitochondria I cancer cells: what is so special about them?. Trends Cell Biol 2008, 18(4):165-173.
22. Warburg O. Ueber den stoffwechsel der tumoren 1930, Constable, London.
23. Seeger P.G., Wolz S. Successful biological control of cancer by combat against the causes 1990, Neuwieder Verlagsgesellschaft, Neuwied, Germany.
24. Krieg R.C., Knuechel R., Schiffmann E., Liotta L.A., Petricoin E.F., Herrmann P.C. Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics 2004, 4(9):2789-2795.
25. John A.P. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid. The impact of this on the treatment of cancer. Med Hypotheses 2001, 57(4):429-431.
26. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res 1979, 39:1141-1149.
27. Kim J.W., Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005, 30:142-150.
28. Pastorino J.G., Hoek J.B., Shulga N. Activation of glycogen synthase kinase 3 beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005, 65:10545-10554.
29. Kim J.W., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006, 66:8927-8930.
30. Michelakis E.D., Webster L., Mackey J.R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 2008, 99(7):989-994.
31. Gonzalez M., Riordan H., Miranda-Massari J. Vitamin C and oxidative DNA damage revisited. J Orthomol Med 2002, 17(4):225-228.
32. Sánchez-Aragó M., Chamorro M., Cuezva J.M. Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis 2010, 31(4):567-576.
33. Macfarlane C.M. Sublethal oxygen deficiency-the primary cause of cancer. Med Hypotheses 2000, 54(2):323-325.
34. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006 Nov, 70(5):1469-1480.
35. Stern R.G., Milestone B.N., Gatenby R.A. Carcinogenesis and the plasma membrane. Med Hypotheses 1999, 52(5):367-372.
36. Kidd J.G., Winzler R.J., Burk D. Comparative glycolytic and respiratory metabolism of homologous normal, benign and malignant rabbit tissues. Cancer Res 1944, 4:655.
37. Kim J.H., Kim S.H., Alferi A., et al. Quercitin an inhibitor of lactate transport and hyperthermic sensitizer of hela cells. Cancer Res 1984, 44(1):102-106.
38. Gonzalez MJ. Miranda-Massari JR, Saul AW. I have Cancer: what should I do? Basic Health Publications, 2009.
39. Gonzalez M.J., Miranda-Massari J.R., Riordan H.D. Vitamin C as an Ergogenic aid. J Orthomol Med 2005, 20(2):100-102.
40. Gonzalez M.J., Miranda-Massari J.R., Mora E.M., Guzmán A., Riordan N.H., Riordan H.D., et al. Orthomolecular oncology review: ascorbic acid and cancer 25years later. Integr Cancer Ther 2005, 4(1):32-44.
41. Chen Q., Espey M.G., Sun A.Y., Lee J.H., Krishna M.C., Shacter E., et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007, 104(21):8749-8754.
42. Agus D.B., Vera J.C., Golde D.W. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 1999, 59(18):4555-4558.
43. Calvo M.B., Figueroa A., Pulido E.G., Campelo R.G., Aparicio L.A. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010, [pii: 205357].
44. Sakagami H., Satoh K. Modulating factors of radical intensity and cytotoxic activity of ascorbate (review). Anticancer Res 1997, 5A:3513-3520.
45. Kamarova S.V., Ataullahanov F.I., Globus L.K. Bioenergetics and mitochondria transmembrane potential during differentiation of osteoblasts. Am J Cell Physiol 2000, 279:1220-1229.
46. Chung TL, Brena RM, Kolle G, Grimmond SM, Berman BP, Laird PW, Pera MF, Wolvetang EJ. Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells 2010 Aug 4 [Epub ahead of print].
47. Eldridge C.F., Bunge M.B., Bunge R.P., Wood P.M. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 1987, 105(2):1023-1034.
48. G.D. Dakubo. Mitochondrial genetics and cancer. The Warburg phenomenon and other metabolic alterations of cancer cells. Springer-Verlag Berlin Heidelberg; 2010. p. 39-66. [Chapter 2].